Log on / register
Feedback | Support | My details
Hypometabolism as a therapeutic target in Alzheimer's disease.
Costantini LC, Barr LJ, Vogel JL, Henderson ST
BMC Neurosci 2008, 9 Suppl 2:S16
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.


Research
Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial
Henderson ST, Vogel JL, Barr LJ, Garvin F, Jones JJ, Costantini LC
Nutrition & Metabolism 2009, 6:31 (10 August 2009)
[Full text] [PubMed Central] [PubMed] [Related articles]

You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.